Biology

Innovaderm Executes Multi-Year Enterprise Agreement with Medrio



SAN FRANCISCO (PRWEB) February 12, 2019 Innovaderm Research, Inc., an innovative clinical research organization (CRO) specializing in dermatology, has finalized a deal to extend their use of Medrio, the leading provider of eClinical technology for early-phase pharma, medical device, and diagn…

Source link

Related posts

Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala

Newsemia

Extensive loss of cell-cycle and DNA repair genes in an ancient lineage of bipolar budding yeasts

Newsemia

The Concept of Successful Aging is Harmful to Research and Development

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World